Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive zonisamide in primary generalized tonic-clonic seizures
2007-003557-91Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in idiopathic epilepsy (IGE) and generalized tonic-clonic seizure (GTCS) comparing Adjunctive zonisamide with Adjunctive placebo (2 arms). Primary endpoint: Responder rate during maintenance phase. Started Nov 2007; status: completed.
02
Drugs
zonisamide
03
Conditions
idiopathic epilepsy (IGE)generalized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on 2007-003557-91.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003557-91.